UNDERSTAND YOUR OPTIONS

Cancer imaging & treatment, by diagnosis.

The right scan or therapy depends on your cancer type, prior treatment, and the question your care team needs to answer.

Start with your cancer type.

IMAGING

Prostate cancer

PSMA PET/CT
PSMA PET/CT can help evaluate prostate cancer in appropriate clinical settings. The tracer, clinical question, and referral determine whether it is suitable.

Explore this service

IMAGING

Breast cancer

FES PET/CT
FES PET evaluates estrogen receptor–positive lesions in recurrent or metastatic breast cancer as an adjunct to biopsy. It does not replace a biopsy when one is indicated.

Explore this service

IMAGING & TREATMENT INFORMATION

Thyroid cancer

Thyroid imaging & radioactive iodine
Thyroid cancer imaging is owner-listed. Radioactive iodine is a treatment option for selected iodine-avid differentiated cancers, including papillary and follicular thyroid cancer.

Explore this service

TREATMENT INFORMATION

Neuroendocrine tumors

Lutathera
Lutathera is used for somatostatin receptor–positive gastroenteropancreatic neuroendocrine tumors: cancers arising in the gastrointestinal tract or pancreas. It is not a treatment for every neuroendocrine tumor.

Explore this service

Imaging is used to evaluate disease. Treatment is intended to act on it. An imaging referral does not mean that a targeted treatment is appropriate or currently available.

FDG PET/CT for other cancers

FDG PET/CT is used in oncology for selected clinical questions. For example, it may help assess lung cancer or lymphoma. The usefulness of a scan varies by cancer type and situation; an abnormal scan is not, by itself, a cancer diagnosis.

Learn more: PET/CT: RadiologyInfo (ACR/RSNA)

Examples: lung cancer imaging and lymphoma imaging (ACR/RSNA).

Learn about FDG PET/CT

Targeted therapies are cancer-specific.

Prostate cancer

Pluvicto is a targeted radioactive treatment for eligible patients with PSMA-positive metastatic prostate cancer.

Explore this service

Neuroendocrine tumors

Lutathera is a receptor-targeted treatment for eligible gastroenteropancreatic neuroendocrine tumors.

Explore this service

Thyroid cancer

Radioactive iodine may be considered for selected papillary and follicular thyroid cancers that take up iodine.

Explore this service

Contact Fusion to confirm current treatment availability and the records needed for specialist review. These pages explain treatment options; they do not confirm eligibility or an available treatment appointment.

Let’s help you take the next step.

Call our Las Vegas team to discuss the requested study, a referral, or a cost estimate.

Call (702) 720-4392